相似文献
1
Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2012 Dec;18(4):357-9. doi: 10.3350/cmh.2012.18.4.357. Epub 2012 Dec 21.
2
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2012 Dec;18(4):383-90. doi: 10.3350/cmh.2012.18.4.383. Epub 2012 Dec 21.
3
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.
J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):47-56.
4
Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease.
Pediatrics. 2009 Dec;124(6):e1221-7. doi: 10.1542/peds.2008-3087.
5
The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease.
Wien Klin Wochenschr. 2012 Aug;124(15-16):526-31. doi: 10.1007/s00508-012-0211-4. Epub 2012 Aug 1.
6
[Nonalcoholic fatty liver disease and psoriasis].
Actas Dermosifiliogr. 2010 Oct;101(8):657-8.
7
Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children.
J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):114-8. doi: 10.1097/MPG.0b013e318291fefe.
8
[The efficacy of ezetimibe on nonalcoholic fatty liver disease (NAFLD)].
Nihon Shokakibyo Gakkai Zasshi. 2011 Aug;108(8):1383-92.
9
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Am J Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec 20.
10
Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study.
Sci Rep. 2016 Aug 3;6:31006. doi: 10.1038/srep31006.
引用本文的文献
1
Biochemical Profile Variations Among Type 2 Diabetic Patients Stratified by Hemoglobin A1c Levels in a Saudi Cohort: A Retrospective Study.
J Clin Med. 2025 Jul 28;14(15):5324. doi: 10.3390/jcm14155324.
2
The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.
Cureus. 2025 May 30;17(5):e85074. doi: 10.7759/cureus.85074. eCollection 2025 May.
3
Bilirubin metabolism in relation to cancer.
Front Oncol. 2025 Apr 11;15:1570288. doi: 10.3389/fonc.2025.1570288. eCollection 2025.
4
Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
Metabolism. 2025 Feb;163:156081. doi: 10.1016/j.metabol.2024.156081. Epub 2024 Nov 22.
5
The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review.
J Clin Transl Hepatol. 2024 Nov 28;12(11):939-948. doi: 10.14218/JCTH.2024.00156. Epub 2024 Oct 21.
6
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.
Clin Sci (Lond). 2022 Sep 30;136(18):1347-1366. doi: 10.1042/CS20220572.
7
Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin.
Antioxidants (Basel). 2022 Jan 18;11(2):179. doi: 10.3390/antiox11020179.
8
Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate.
Front Pharmacol. 2020 Dec 18;11:594574. doi: 10.3389/fphar.2020.594574. eCollection 2020.
9
Bilirubin as a metabolic hormone: the physiological relevance of low levels.
Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E191-E207. doi: 10.1152/ajpendo.00405.2020. Epub 2020 Dec 7.
10
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity.
Int J Mol Sci. 2020 Nov 29;21(23):9091. doi: 10.3390/ijms21239091.
本文引用的文献
1
A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers.
PLoS One. 2012;7(5):e37241. doi: 10.1371/journal.pone.0037241. Epub 2012 May 15.
2
Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH).
Aliment Pharmacol Ther. 2012 Jun;35(12):1416-23. doi: 10.1111/j.1365-2036.2012.05114.x. Epub 2012 Apr 29.
3
Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response.
Clin Biochem. 2012 Feb;45(3):272-4. doi: 10.1016/j.clinbiochem.2011.11.017. Epub 2011 Dec 16.
4
Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults.
Nutr Metab Cardiovasc Dis. 2013 Jan;23(1):31-7. doi: 10.1016/j.numecd.2011.03.001. Epub 2011 Jun 23.
5
High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006.
J Clin Med Res. 2010 Oct 11;2(5):201-6. doi: 10.4021/jocmr425w.
6
Relationship between nonalcoholic fatty liver disease and metabolic syndrome.
J Dig Dis. 2011 Apr;12(2):125-30. doi: 10.1111/j.1751-2980.2011.00487.x.
7
The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus.
Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):458-63. doi: 10.1161/ATVBAHA.110.211789. Epub 2010 Nov 18.
8
High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy.
Tohoku J Exp Med. 2010 Jun;221(2):133-40. doi: 10.1620/tjem.221.133.
9
The natural history of non-alcoholic fatty liver disease.
Dig Dis. 2010;28(1):162-8. doi: 10.1159/000282081. Epub 2010 May 7.
10
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.
Hepatology. 2010 Jun;51(6):1979-87. doi: 10.1002/hep.23593.
Zotero 插件